Advanced search
Publication Cover
Expert Review of Vaccines Volume 11, 2012 - Issue 2
Submit an article Journal homepage
64
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Hepatitis B vaccination in pregnancy

Nicholas Wood National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS), Locked Bag 4001, Westmead, New South Wales 2145, Australia and The University of Sydney, New South Wales, Australia and The Children’s Hospital at Westmead, Sydney, Australia. [email protected]
&
David Isaacs The Children’s Hospital at Westmead, Sydney, Australia
Pages 125-127 | Published online: 09 Jan 2014

References

  • Goldstein ST, Fiore AE. Toward the global elimination of hepatitis B virus transmission. J. Pediatr.139(3), 343–345 (2001).
  • WHO. Hepatitis B vaccines: WHO position paper – recommendations. Vaccine28(3), 589–590 (2010).
  • Plotkin S, Orenstein WA, Offit PA. Hepatitis B. In: Vaccines (Fifth Edition). Saunders Elsevier, Philadelphia, PA, USA (2008).
  • Lee C, Gong Y, Brok J et al. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst. Rev.2, CD004790 (2006).
  • Lee C, Gong Y, Brok J et al. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ332(7537), 328–336 (2006).
  • Isaacs D, Kilham H, Alexander S et al. Ethical issues in preventing mother-to-child transmission of hepatitis B by immunisation. Vaccine29(37), 6159–6162 (2011).
  • Ip H, Lelie P, Wong V et al. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet1(8635), 406–410 (1989).
  • Xu ZY, Duan SC, Margoliis HS et al. Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. United States–People’s Republic of China Study Group on Hepatitis B. J. Infect. Dis.171(1), 54–60 (1995).
  • Mast E, Margolis H, Fiore A et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Morb. Mortal. Wkly Rep.54 RR(16), 1–23 (2005).
  • Mast E, Weinbaum C, Fiore A et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) part 2: immunization of adults MMWR Morb. Mortal. Wkly Rep.55 RR(16), 1–25 (2006).
  • Gambarin-Gelwan M. Hepatitis B in pregnancy. Clin. Liver Dis.11(4), 945–963 (2007).
  • Xu D, Yan Y, Choi B et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case control study. J. Med. Virol.67(1), 20–26 (2002).
  • Levy M, Koren G. Hepatitis B in pregnancy: maternal and fetal safety. Am. J. Perinatol.8(3), 227–232 (1991).
  • Ngui S, Andrews N, Underhill G, Heptonstall J, Teo C. Failed postnatal prophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin. Infect. Dis.27(1), 100–106 (1998).
  • Degli Esposti S, Shah D. Hepatitis B in pregnancy: challenges and treatment. Gastro Clin. Nth. Am.40(2), 355–372 (2011).
  • Sangkomkamhang US, Lumbiganon P, Laopaiboon M. Hepatitis B vaccination during pregnancy for preventing infant infection. Cochrane Database Syst. Rev.3, CD007879 (2011).
  • Shi Z, Li X Ma L, Yang Y. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother to child transmission – a meta analysis. Int. J. Infect. Dis.14(7), e622–e634 (2010).
  • Yuan J, Lin J, Xu A et al. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomised study. J. Med. Virol.13(9), 597–604 (2006).
  • Yu M, Ji Y, Jiang H, Ju L, Wu K, Kan N. Efficacy of peripartum antiviral treatment for hepatic failure due to hepatitis B virus. Int. J. Gynaecol. Obstet.114(1), 33–36 (2011).
  • Shi Z, Yang Y, Ma L, Li X, Schreiber A. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol.116(1), 147–159 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.